GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$40.01 USD
+0.15 (0.38%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $40.01 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Income Statements
Fiscal Year end for GSK PLC Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 37,725 | 36,271 | 46,910 | 43,783 | 43,100 |
Cost Of Goods | 10,654 | 11,817 | 15,955 | 15,028 | 15,148 |
Gross Profit | 27,071 | 24,454 | 30,955 | 28,755 | 27,953 |
Selling & Adminstrative & Depr. & Amort Expenses | 18,681 | 16,497 | 22,428 | 18,762 | 19,064 |
Income After Depreciation & Amortization | 8,390 | 7,957 | 8,527 | 9,993 | 8,889 |
Non-Operating Income | 138 | 92 | 34 | 99 | 220 |
Interest Expense | 985 | 1,087 | 1,078 | 1,145 | 1,165 |
Pretax Income | 7,543 | 6,961 | 7,483 | 8,947 | 7,944 |
Income Taxes | 940 | 874 | 476 | 745 | 1,217 |
Minority Interest | 473 | 823 | 978 | 820 | 796 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 6,603 | 6,087 | 7,008 | 8,202 | 6,727 |
Extras & Discontinued Operations | 0 | 13,235 | 0 | 0 | 0 |
Net Income (GAAP) | 6,130 | 18,499 | 6,030 | 7,382 | 5,931 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11,244 | 10,613 | 8,527 | 13,012 | 11,869 |
Depreciation & Amortization (Cash Flow) | 2,854 | 2,656 | 0 | 3,019 | 2,980 |
Income After Depreciation & Amortization | 8,390 | 7,957 | 8,527 | 9,993 | 8,889 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 2,055.50 | 2,042.00 | 2,002.28 | 1,990.40 | 1,978.70 |
Diluted EPS Before Non-Recurring Items | 3.86 | 3.46 | 3.89 | 3.73 | 3.96 |
Diluted Net EPS (GAAP) | 2.98 | 9.06 | 3.01 | 3.66 | 2.96 |
Fiscal Year end for GSK PLC Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 9,337.02 | 9,980.06 | 10,313.29 | 8,987.57 |
Cost Of Goods | NA | 2,498.16 | 2,998.47 | 2,876.13 | 2,419.06 |
Gross Profit | NA | 6,838.86 | 6,981.60 | 7,437.16 | 6,568.52 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4,949.40 | 6,268.69 | 4,969.92 | 3,887.77 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,889.46 | 712.91 | 2,467.24 | 2,680.75 |
Non-Operating Income | NA | 39.31 | 34.86 | 30.38 | 38.82 |
Interest Expense | NA | 210.50 | 276.53 | 230.39 | 231.64 |
Pretax Income | NA | 1,718.28 | 471.24 | 2,267.23 | 2,487.92 |
Income Taxes | NA | 347.46 | -23.24 | 325.34 | 303.01 |
Minority Interest | NA | 44.38 | 61.28 | 88.61 | 151.50 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1,370.82 | 494.48 | 1,941.89 | 2,184.92 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1,326.43 | 433.20 | 1,853.28 | 2,033.41 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 2,034.50 | 2,058.82 | 2,056.00 | 2,026.50 |
Diluted EPS Before Non-Recurring Items | NA | 1.09 | 0.72 | 1.26 | 0.97 |
Diluted Net EPS (GAAP) | NA | 0.64 | 0.20 | 0.90 | 0.99 |